42 results
6-K
EX-99
BLRX
Bioline Rx Ltd
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
- for the treatment of celiac disease - with the Finnish National Supervisory Authority for Welfare and Health (Valvira). The relevant ethics committee has already
6-K
EX-1
BLRX
Bioline Rx Ltd
21 Nov 11
BioLineRx Announces Receipt of Approval in India
12:00am
), a biopharmaceutical development company, announced today that it has received approval from the Indian regulatory authorities and the Indian local ethics committees
6-K
EX-99
BLRX
Bioline Rx Ltd
2 Mar 15
Current report (foreign)
12:00am
(Bundesinstitut für Arzneimittel und Medizinprodukte) and the relevant ethics committees have been made.
Dr. Kinneret Savitsky, Chief Executive Officer
6-K
EX-99
odwu2j
29 Jul 13
BioLineRx Announces CE-Mark Registration
12:00am
20-F/A
EX-4.40
w7101fhda1 xwh
31 May 16
Annual report (foreign) (amended)
12:00am
F-1
EX-10.17
g4u8 223n977mpzz
24 Sep 10
Registration statement (foreign)
12:00am
6-K
EX-99
8ak2o730
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
20FR12B
EX-4.17
f463it2k
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
6-K
EX-99
ex7mofzx7mq
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
20-F
0rf3wg6
22 Mar 12
Annual report (foreign)
12:00am
F-1
avg4evb
24 Sep 10
Registration statement (foreign)
12:00am